• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EZH2 通过与 HDAC1/HDAC2 和 Snail 形成共抑制复合物来抑制 E-钙黏蛋白,从而支持鼻咽癌细胞的侵袭能力。

EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.

机构信息

The State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-Sen University, Guangzhou, China.

出版信息

Oncogene. 2012 Feb 2;31(5):583-94. doi: 10.1038/onc.2011.254. Epub 2011 Jun 20.

DOI:10.1038/onc.2011.254
PMID:21685935
Abstract

The enhancer of zeste homolog 2 (EZH2) is upregulated and has an oncogenic role in several types of human cancer. However, the abnormalities of EZH2 and its underlying mechanisms in the pathogenesis of nasopharyngeal carcinoma (NPC) remain unknown. In this study, we found that high expression of EZH2 in NPC was associated closely with an aggressive and/or poor prognostic phenotype (P<0.05). In NPC cell lines, knockdown of EZH2 by short hairpin RNA was sufficient to inhibit cell invasiveness/metastasis both in vitro and in vivo, whereas ectopic overexpression of EZH2 supported NPC cell invasive capacity with a decreased expression of E-cadherin. In addition, ablation of endogenous Snail in NPC cells virtually totally prevented the repressive activity of EZH2 to E-cadherin, indicating that Snail might be a predominant mediator of EZH2 to suppress E-cadherin. Furthermore, co-immunoprecipitation (IP), chromatin IP and luciferase reporter assays demonstrated that in NPC cells, (1) EZH2 interacted with HDAC1/HDAC2 and Snail to form a repressive complex; (2) these components interact in a linear fashion, not in a triangular fashion, that is, HDAC1 or HDAC2 bridge the interaction between EZH2 and Snail; and (3) the EZH2/HDAC1/2/Snail complex could closely bind to the E-cadherin promoter by Snail, but not YY1, to repress E-cadherin. The data provided in this report suggest a critical role of EZH2 in the control of cell invasion and/or metastasis by forming a co-repressor complex with HDAC1/HDAC2/Snail to repress E-cadherin, an activity that might be responsible, at least in part, for the development and/or progression of human NPCs.

摘要

增强子结合锌指蛋白 2(EZH2)在几种类型的人类癌症中上调并具有致癌作用。然而,EZH2 的异常及其在鼻咽癌(NPC)发病机制中的潜在机制尚不清楚。在本研究中,我们发现 NPC 中 EZH2 的高表达与侵袭性和/或不良预后表型密切相关(P<0.05)。在 NPC 细胞系中,短发夹 RNA 敲低 EZH2 足以抑制体外和体内的细胞侵袭/转移,而 EZH2 的异位过表达支持 NPC 细胞的侵袭能力,同时降低 E-钙粘蛋白的表达。此外,NPC 细胞中内源性 Snail 的缺失几乎完全阻止了 EZH2 对 E-钙粘蛋白的抑制活性,表明 Snail 可能是 EZH2 抑制 E-钙粘蛋白的主要介质。此外,共免疫沉淀(IP)、染色质 IP 和荧光素酶报告基因测定表明,在 NPC 细胞中,(1)EZH2 与 HDAC1/HDAC2 和 Snail 相互作用形成抑制复合物;(2)这些成分以线性方式而不是三角形方式相互作用,即 HDAC1 或 HDAC2 桥接 EZH2 和 Snail 之间的相互作用;(3)EZH2/HDAC1/2/Snail 复合物可以通过 Snail 紧密结合到 E-钙粘蛋白启动子上,而不是 YY1,从而抑制 E-钙粘蛋白。本报告提供的数据表明,EZH2 通过与 HDAC1/HDAC2/Snail 形成共抑制复合物来抑制 E-钙粘蛋白,从而在控制细胞侵袭和/或转移中发挥关键作用,这种活性可能至少部分负责人类 NPC 的发生和/或进展。

相似文献

1
EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.EZH2 通过与 HDAC1/HDAC2 和 Snail 形成共抑制复合物来抑制 E-钙黏蛋白,从而支持鼻咽癌细胞的侵袭能力。
Oncogene. 2012 Feb 2;31(5):583-94. doi: 10.1038/onc.2011.254. Epub 2011 Jun 20.
2
MIER3 induces epithelial-mesenchymal transition and promotes breast cancer cell aggressiveness via forming a co-repressor complex with HDAC1/HDAC2/Snail.MIER3 通过与 HDAC1/HDAC2/Snail 形成共抑制复合物诱导上皮-间充质转化并促进乳腺癌细胞侵袭。
Exp Cell Res. 2021 Sep 1;406(1):112722. doi: 10.1016/j.yexcr.2021.112722. Epub 2021 Jul 6.
3
E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex.E-钙黏蛋白在体内调节胰腺癌的转移,并被一种SNAIL/HDAC1/HDAC2抑制复合物所抑制。
Gastroenterology. 2009 Jul;137(1):361-71, 371.e1-5. doi: 10.1053/j.gastro.2009.04.004. Epub 2009 Apr 9.
4
Enhancer of zeste homolog 2 overexpression in nasopharyngeal carcinoma: an independent poor prognosticator that enhances cell growth.增强子结合锌指蛋白 2 在鼻咽癌中的过表达:一个独立的预后不良因素,可增强细胞生长。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):597-604. doi: 10.1016/j.ijrobp.2010.11.062. Epub 2011 Feb 6.
5
Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex.蜗牛蛋白通过募集Sin3A/组蛋白去乙酰化酶1(HDAC1)/组蛋白去乙酰化酶2(HDAC2)复合物介导E-钙黏蛋白的抑制。
Mol Cell Biol. 2004 Jan;24(1):306-19. doi: 10.1128/MCB.24.1.306-319.2004.
6
Repression of E-cadherin by the polycomb group protein EZH2 in cancer.多梳蛋白EZH2在癌症中对E-钙黏蛋白的抑制作用。
Oncogene. 2008 Dec 11;27(58):7274-84. doi: 10.1038/onc.2008.333. Epub 2008 Sep 22.
7
Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma.zeste 同源物2增强子(EZH2)通过对肾细胞癌中E-钙黏蛋白的表观遗传抑制促进肿瘤细胞迁移和侵袭。
BJU Int. 2016 Feb;117(2):351-62. doi: 10.1111/bju.12702. Epub 2015 Apr 21.
8
Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells.在胃癌细胞中,zeste同源物2增强子通过介导组蛋白H3甲基化来下调E-钙黏蛋白。
Cancer Sci. 2008 Apr;99(4):738-46. doi: 10.1111/j.1349-7006.2008.00743.x.
9
Hepatitis C virus core protein interacts with Snail and histone deacetylases to promote the metastasis of hepatocellular carcinoma.丙型肝炎病毒核心蛋白与Snail和组蛋白去乙酰化酶相互作用以促进肝细胞癌的转移。
Oncogene. 2016 Jul 14;35(28):3626-35. doi: 10.1038/onc.2015.428. Epub 2015 Nov 9.
10
SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.SOX4与EZH2和HDAC3相互作用,以抑制侵袭性食管癌细胞中的微小RNA-31。
Mol Cancer. 2015 Feb 3;14:24. doi: 10.1186/s12943-014-0284-y.

引用本文的文献

1
Epithelial-mesenchymal transition in colorectal cancer metastasis and progression: molecular mechanisms and therapeutic strategies.上皮-间质转化在结直肠癌转移和进展中的作用:分子机制与治疗策略
Cell Death Discov. 2025 Jul 22;11(1):336. doi: 10.1038/s41420-025-02593-8.
2
EZH2 inhibitor SHR2554 enhances the anti-tumor efficacy of HDAC inhibitor Chidamide through STAT1 in T-cell lymphoma.EZH2抑制剂SHR2554通过STAT1增强HDAC抑制剂西达本胺在T细胞淋巴瘤中的抗肿瘤疗效。
Cell Death Dis. 2025 Jul 14;16(1):522. doi: 10.1038/s41419-025-07775-x.
3
HDAC1/2-mediated deacetylation of KLF9 promotes the malignant progression of nasopharyngeal carcinoma via CDH17.
HDAC1/2介导的KLF9去乙酰化通过CDH17促进鼻咽癌的恶性进展。
Oncogene. 2025 Jul 4. doi: 10.1038/s41388-025-03471-4.
4
The regulatory role of m6A in cancer metastasis.m6A在癌症转移中的调控作用。
Front Cell Dev Biol. 2025 Apr 28;13:1539678. doi: 10.3389/fcell.2025.1539678. eCollection 2025.
5
Integrative analysis of taurine metabolism-related genes prognostic signature with immunotherapy and identification of ABCB1 and GORASP1 as key genes in nasopharyngeal carcinoma.牛磺酸代谢相关基因预后特征与免疫治疗的综合分析及ABCB1和GORASP1作为鼻咽癌关键基因的鉴定
Amino Acids. 2025 Apr 24;57(1):21. doi: 10.1007/s00726-025-03452-7.
6
Mechanisms of HDACs in cancer development.组蛋白去乙酰化酶在癌症发展中的作用机制。
Front Immunol. 2025 Apr 7;16:1529239. doi: 10.3389/fimmu.2025.1529239. eCollection 2025.
7
EZH2 suppresses IR-induced ferroptosis by forming a co-repressor complex with HIF-1α to inhibit ACSL4: Targeting EZH2 enhances radiosensitivity in KDM6A-deficient esophageal squamous carcinoma.EZH2通过与HIF-1α形成共抑制复合物来抑制铁死亡诱导因子(IR)诱导的铁死亡,从而抑制ACSL4:靶向EZH2可增强KDM6A缺陷型食管鳞状细胞癌的放射敏感性。
Cell Death Differ. 2025 Feb 7. doi: 10.1038/s41418-025-01451-5.
8
Relationship of Signaling Pathways between RKIP Expression and the Inhibition of EMT-Inducing Transcription Factors SNAIL1/2, TWIST1/2 and ZEB1/2.RKIP表达与上皮-间质转化诱导转录因子SNAIL1/2、TWIST1/2和ZEB1/2抑制之间的信号通路关系
Cancers (Basel). 2024 Sep 17;16(18):3180. doi: 10.3390/cancers16183180.
9
Paeonia genus: a systematic review of active ingredients, pharmacological effects and mechanisms, and clinical applications for the treatment of cancer.芍药属植物:治疗癌症的活性成分、药理作用及机制和临床应用的系统评价。
Arch Pharm Res. 2024 Sep;47(8-9):677-695. doi: 10.1007/s12272-024-01512-2. Epub 2024 Sep 22.
10
HDAC6-mediated deacetylation of FLOT2 maintains stability and tumorigenic function of FLOT2 in nasopharyngeal carcinoma.HDAC6 介导的 FLOT2 去乙酰化作用维持了鼻咽癌中 FLOT2 的稳定性和致瘤功能。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 May 28;49(5):687-697. doi: 10.11817/j.issn.1672-7347.2024.240077.